UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting the epidermal growth factor receptor

British journal of cancer, 2004-08, Vol.91 (3), p.418-424

2004

Volltextzugriff (PDF)

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours

British journal of cancer, 2017-11, Vol.117 (11), p.1592-1599

2017

Volltextzugriff (PDF)

Molecular Mechanisms Underlying the Divergent Roles of SPARC in Human Carcinogenesis

Carcinogenesis (New York), 2014-05, Vol.35 (5), p.967-973

2014

Volltextzugriff (PDF)

mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)

Annals of oncology, 2013-04, Vol.24 (4), p.965-973

2013

Volltextzugriff (PDF)

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040

Annals of oncology, 2024-06, Vol.35 (6), p.537-548

2024

Volltextzugriff (PDF)

A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC)

Annals of oncology, 2018-06, Vol.29, p.v103-v103

2018

Volltextzugriff (PDF)

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

Annals of oncology, 2010-10, Vol.21 (10), p.1999-2004

2010

Volltextzugriff (PDF)

A phase II study of carboplatin and paclitaxel in esophageal cancer

Annals of oncology, 2004-06, Vol.15 (6), p.960-965

2004

Volltextzugriff (PDF)

Phase II Study of Gemcitabine, Cisplatin, and Infusional Fluorouracil in Advanced Pancreatic Cancer

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2920-2925

2003

Volltextzugriff (PDF)

A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)

Annals of oncology, 2017-06, Vol.28, p.iii150-iii150

2017

Volltextzugriff (PDF)

Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer

Oncogene, 2014-11, Vol.33 (47), p.5450-5456

2014

Volltextzugriff (PDF)

Sites of metastasis and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO)

Annals of oncology, 2018-10, Vol.29, p.viii433-viii433

2018

Volltextzugriff (PDF)

Sarcopenia and inflammation predicts survival in advanced stage cancer patients (pts) treated with immunotherapy (IO)

Annals of oncology, 2018-10, Vol.29, p.viii42-viii42

2018

Volltextzugriff (PDF)

PD-019ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii109-ii109

2016

Volltextzugriff (PDF)

A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies

British journal of cancer, 2013-03, Vol.108 (4), p.762-765

2013

Volltextzugriff (PDF)

Developments in the Systemic Therapy of Pancreatic Cancer

Cancer investigation, 2003, Vol.21 (1), p.73-86

2003

Volltextzugriff (PDF)

Broad targeting of angiogenesis for cancer prevention and therapy

Seminars in cancer biology, 2015-12, Vol.35 (Suppl), p.S224-S243

2015

Volltextzugriff (PDF)

Analysis of liver-directed therapies in U.S. cancer patients

Current oncology (Toronto), 2015-12, Vol.22 (6), p.e457-461

2015

Volltextzugriff (PDF)

A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer

HPB (Oxford, England), 2016-04, Vol.18, p.e342-e343

2016

Volltextzugriff (PDF)

Comparison of DNA content parameters in paired, fresh tissue pretreatment biopsies and surgical resections from squamous cell carcinoma of the head and neck

Otolaryngology-head and neck surgery, 2003-02, Vol.128 (2), p.169-177

2003

Volltextzugriff (PDF)

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer

International journal of radiation oncology, biology, physics, 2004-06, Vol.59 (2), p.454-459

2004

Volltextzugriff (PDF)

P-76 Genomic and transcriptomic characterization of pancreatic neuroendocrine tumors reveals novel therapeutic candidates

Annals of oncology, 2023-06, Vol.34, p.S40-S41

2023

Volltextzugriff (PDF)

172P HER2 expression across solid tumors and real-world implications for use of fam-trastuzumab deruxtecan-nxki (T-Dxd)

Annals of oncology, 2024-09, Vol.35, p.S284-S284

2024

Volltextzugriff (PDF)

PD-4 A phase I trial of trifluridine/tipiracil in combination with nanoliposomal irinotecan in advanced GI cancers

Annals of oncology, 2021-07, Vol.32, p.S200

2021

Volltextzugriff (PDF)

Toxicity Following Multimodal Treatment of Pancreatic Cancer

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e190

2022

Volltextzugriff (PDF)

1 – 25 von 308

Suche als RSS-Feed

Aktive Filter

ThemaRadiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(293)
Mit Volltextzugriff
(264)

Publikationsform

Artikel
(305)
Buchkapitel
(3)

Sprache

Englisch
(308)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(125)
Oncology
(107)
Humans
(91)
Female
(63)
Male
(53)
Middle Aged
(51)
Aged
(43)
Adult
(37)
Tumors
(30)
Chemotherapy
(24)
Cancer
(23)
Pancreatic Cancer
(23)
Biological And Medical Sciences
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Medical Sciences
(20)
Pancreatic Neoplasms - Drug Therapy
(20)
Patients
(18)
Treatment Outcome
(18)
Aged, 80 And Over
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Targeting the epidermal growth factor receptor

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours

Molecular Mechanisms Underlying the Divergent Roles of SPARC in Human Carcinogenesis

mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040

A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC)

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

A phase II study of carboplatin and paclitaxel in esophageal cancer

Phase II Study of Gemcitabine, Cisplatin, and Infusional Fluorouracil in Advanced Pancreatic Cancer

A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)

Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer

Sites of metastasis and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO)

Sarcopenia and inflammation predicts survival in advanced stage cancer patients (pts) treated with immunotherapy (IO)

PD-019ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)

A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies

Developments in the Systemic Therapy of Pancreatic Cancer

Broad targeting of angiogenesis for cancer prevention and therapy

Analysis of liver-directed therapies in U.S. cancer patients

A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer

Comparison of DNA content parameters in paired, fresh tissue pretreatment biopsies and surgical resections from squamous cell carcinoma of the head and neck

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer

P-76 Genomic and transcriptomic characterization of pancreatic neuroendocrine tumors reveals novel therapeutic candidates

172P HER2 expression across solid tumors and real-world implications for use of fam-trastuzumab deruxtecan-nxki (T-Dxd)

PD-4 A phase I trial of trifluridine/tipiracil in combination with nanoliposomal irinotecan in advanced GI cancers

Toxicity Following Multimodal Treatment of Pancreatic Cancer

Aktive Filter

Suchergebnisse filtern